Advanced assessment
Evidence inventory, leadership interview, capability and gap review, prioritized plan and site profile.
Optional consulting
Organize your site’s capability evidence.
Assessment and improvement planning separate from investigator services. Scope, deliverables and timing are agreed before an engagement is accepted.
Comprehensive assessment
Advanced review plus expanded reconciliation of investigators, staff, facilities, equipment, quality, systems and feasibility.
Eleven areas of review
- Site identity and operating model
- Investigator and staff qualifications
- Research experience and performance evidence
- Participant access and aggregate feasibility
- Facilities, equipment, laboratory and logistics
- Regulatory documents and quality systems
- Safety and clinical support
- Electronic systems and data integrity
- Profiles and sponsor/CRO presentation
- Startup capacity and administrative responsiveness
- Therapeutic, phase and protocol fit
Assessment outputs
A findings report, prioritized action register, 30/60/90-day plan and sponsor-facing capability profile. Scope, fees, timing and deliverables are agreed in writing.
Findings distinguish verified, documented, observed, attested, derived, missing, expired and inconsistent evidence. Conclusions depend on the protocol; no site certification is offered.
We assess and recommend; your site decides.
The site supplies complete materials and controls implementation, personnel, vendors and budget. Site management, hiring, study acquisition, implementation and selection guarantees are excluded. Assessment does not reserve or influence a PI appointment.
Use aggregate evidence without patient information. The site or its authorized vendor executes population queries; RenuviaMD may recommend the query structure.